94 related articles for article (PubMed ID: 16857690)
1. Optimal sampling strategies for early pharmacodynamic measures in tuberculosis.
Davies GR; Khoo SH; Aarons LJ
J Antimicrob Chemother; 2006 Sep; 58(3):594-600. PubMed ID: 16857690
[TBL] [Abstract][Full Text] [Related]
2. Clinical development of anti-tuberculosis drugs.
Mitchison DA
J Antimicrob Chemother; 2006 Sep; 58(3):494-5. PubMed ID: 16840430
[TBL] [Abstract][Full Text] [Related]
3. Early bactericidal activity of high-dose rifampin in patients with pulmonary tuberculosis evidenced by positive sputum smears.
Diacon AH; Patientia RF; Venter A; van Helden PD; Smith PJ; McIlleron H; Maritz JS; Donald PR
Antimicrob Agents Chemother; 2007 Aug; 51(8):2994-6. PubMed ID: 17517849
[TBL] [Abstract][Full Text] [Related]
4. The early bactericidal activity of anti-tuberculosis drugs: a literature review.
Donald PR; Diacon AH
Tuberculosis (Edinb); 2008 Aug; 88 Suppl 1():S75-83. PubMed ID: 18762155
[TBL] [Abstract][Full Text] [Related]
5. A multicentre comparison of a novel surrogate marker for determining the specific potency of anti-tuberculosis drugs.
Gosling RD; Heifets L; Gillespie SH
J Antimicrob Chemother; 2003 Sep; 52(3):473-6. PubMed ID: 12888596
[TBL] [Abstract][Full Text] [Related]
6. A novel method for evaluating the antimicrobial activity of tuberculosis treatment regimens.
Gillespie SH; Charalambous BM
Int J Tuberc Lung Dis; 2003 Jul; 7(7):684-9. PubMed ID: 12870691
[TBL] [Abstract][Full Text] [Related]
7. Early clinical development of anti-tuberculosis drugs: science, statistics and sterilizing activity.
Davies GR
Tuberculosis (Edinb); 2010 May; 90(3):171-6. PubMed ID: 20382567
[TBL] [Abstract][Full Text] [Related]
8. Sputum conversion among patients with pulmonary tuberculosis: are there implications for removal of respiratory isolation?
Fortún J; Martín-Dávila P; Molina A; Navas E; Hermida JM; Cobo J; Gómez-Mampaso E; Moreno S
J Antimicrob Chemother; 2007 Apr; 59(4):794-8. PubMed ID: 17392354
[TBL] [Abstract][Full Text] [Related]
9. [Improvement of routine works and quality control in mycobacterial laboratory].
Suzuki K; Higuchi T
Kekkaku; 2007 Mar; 82(3):217-27. PubMed ID: 17444126
[TBL] [Abstract][Full Text] [Related]
10. Immune parameters as markers of tuberculosis extent of disease and early prediction of anti-tuberculosis chemotherapy response.
Djoba Siawaya JF; Bapela NB; Ronacher K; Veenstra H; Kidd M; Gie R; Beyers N; van Helden P; Walzl G
J Infect; 2008 May; 56(5):340-7. PubMed ID: 18359089
[TBL] [Abstract][Full Text] [Related]
11. Prediction of delayed treatment response in pulmonary tuberculosis: use of time to positivity values of Bactec cultures.
Carroll NM; Uys P; Hesseling A; Lawrence K; Pheiffer C; Salker F; Duncan K; Beyers N; van Helden PD
Tuberculosis (Edinb); 2008 Nov; 88(6):624-30. PubMed ID: 18456556
[TBL] [Abstract][Full Text] [Related]
12. Early and rapid microscopy-based diagnosis of true treatment failure and MDR-TB.
Hamid Salim A; Aung KJ; Hossain MA; Van Deun A
Int J Tuberc Lung Dis; 2006 Nov; 10(11):1248-54. PubMed ID: 17131784
[TBL] [Abstract][Full Text] [Related]
13. Optimizing outpatient serial sputum colony counting for studies of tuberculosis treatment in resource-poor settings.
Sloan DJ; Corbett EL; Butterworth AE; Mwandumba HC; Khoo SH; Mdolo A; Shani D; Kamdolozi M; Allen J; Mitchison DA; Coleman DJ; Davies GR
J Clin Microbiol; 2012 Jul; 50(7):2315-20. PubMed ID: 22573593
[TBL] [Abstract][Full Text] [Related]
14. Time to detection of Mycobacterium tuberculosis in BACTEC systems as a viable alternative to colony counting.
Pheiffer C; Carroll NM; Beyers N; Donald P; Duncan K; Uys P; van Helden P
Int J Tuberc Lung Dis; 2008 Jul; 12(7):792-8. PubMed ID: 18544206
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of kanamycin, ethionamide, PAS and cycloserine in multidrug-resistant pulmonary tuberculosis patients.
Prasad R; Verma SK; Sahai S; Kumar S; Jain A
Indian J Chest Dis Allied Sci; 2006; 48(3):183-6. PubMed ID: 18610675
[TBL] [Abstract][Full Text] [Related]
16. Risk of acquired drug resistance during short-course directly observed treatment of tuberculosis in an area with high levels of drug resistance.
Cox HS; Niemann S; Ismailov G; Doshetov D; Orozco JD; Blok L; Rüsch-Gerdes S; Kebede Y
Clin Infect Dis; 2007 Jun; 44(11):1421-7. PubMed ID: 17479936
[TBL] [Abstract][Full Text] [Related]
17. [Evaluation of care for elderly pulmonary tuberculosis patients].
Sasaki Y; Yamagishi F; Yagi T; Hashimoto T; Bekku R; Kawasaki T; Shinozaki A
Kekkaku; 2007 Oct; 82(10):733-9. PubMed ID: 18018597
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of smear negative pulmonary tuberculosis among patients visiting St. Peter's Tuberculosis Specialized Hospital, Addis Ababa, Ethiopia.
Desta K; Asrat D; Lemma E; Gebeyehu M; Feleke B
Ethiop Med J; 2009 Jan; 47(1):17-24. PubMed ID: 19743776
[TBL] [Abstract][Full Text] [Related]
19. [The specific features of bacillary excretion and drug sensitivity in Mycobacterium tuberculosis in patients with recurrent pulmonary tuberculosis].
Il'iuna TIa; Zhangireev AA; Sidorenko OA
Probl Tuberk Bolezn Legk; 2008; (5):20-2. PubMed ID: 18711814
[TBL] [Abstract][Full Text] [Related]
20. Outcomes of different subgroups of smear-positive retreatment patients under RNTCP in rural West Bengal, India.
Mukherjee A; Sarkar A; Saha I; Biswas B; Bhattacharyya PS
Rural Remote Health; 2009; 9(1):926. PubMed ID: 19260766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
